CATALANO, Alfonso
 Distribuzione geografica
Continente #
NA - Nord America 1.779
EU - Europa 983
AS - Asia 259
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.027
Nazione #
US - Stati Uniti d'America 1.776
UA - Ucraina 227
SE - Svezia 157
IT - Italia 149
IE - Irlanda 115
DE - Germania 108
SG - Singapore 99
DK - Danimarca 88
TR - Turchia 60
FI - Finlandia 59
CN - Cina 50
KR - Corea 47
GB - Regno Unito 31
FR - Francia 25
BE - Belgio 15
AT - Austria 3
CA - Canada 3
BR - Brasile 2
EU - Europa 2
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
ES - Italia 1
IN - India 1
IR - Iran 1
JP - Giappone 1
LU - Lussemburgo 1
MD - Moldavia 1
NL - Olanda 1
PL - Polonia 1
Totale 3.027
Città #
Chandler 257
Jacksonville 229
Fairfield 165
Des Moines 129
Boardman 118
Dublin 115
Woodbridge 76
Ann Arbor 73
Ashburn 73
Wilmington 72
New York 57
Houston 51
Singapore 48
Lawrence 46
Princeton 46
San Mateo 45
Cambridge 43
Seattle 38
Centro 29
San Diego 22
Brussels 14
Helsinki 13
London 7
Porto 7
Wuhan 7
Rome 6
Beijing 5
Santa Clara 5
Wuxi 5
Los Angeles 4
Milan 4
Turin 4
Washington 4
Jiaxing 3
Norwalk 3
Palermo 3
Palo del Colle 3
Vienna 3
Bari 2
Dallas 2
Florence 2
Giugliano in Campania 2
Guangzhou 2
Matelica 2
Novara 2
Pagani 2
Rio de Janeiro 2
Shanghai 2
Shenzhen 2
Venice 2
Vigevano 2
Yiwu 2
Amsterdam 1
Ancona 1
Ascoli Piceno 1
Auburn Hills 1
Bologna 1
Castagneto Carducci 1
Castel Volturno 1
Chisinau 1
Clifton 1
Falkenstein 1
Gent 1
Jinhua 1
Kilburn 1
Kish 1
Longyan 1
Madrid 1
Manchester 1
Marche 1
Modena 1
Montréal 1
Naples 1
Nürnberg 1
Ottawa 1
Pittsford 1
Pune 1
Saltara 1
Santiago 1
Seoul 1
Shaoxing 1
Siena 1
Tappahannock 1
Tokyo 1
Tolentino 1
Toronto 1
Warsaw 1
York 1
Zibo 1
Zurich 1
Totale 1.898
Nome #
Decitabine, differently from DNMT1 silencing, exerts its antiproliferative activity through p21 upregulation in Malignant Pleural Mesothelioma (MPM) cells. 117
USO FARMACEUTICO DI SEMAFORINE 109
Il Celecoxib sensibilizza le cellule tumorali di prostata alla morte cellulare recettore-mediata 107
HIF2α is involved in the expansion of CXCR4-positive cancer stem-like cells in renal cell carcinoma 106
Emerging Role of Stromal Fibroblasts in Epithelial Cancer 93
Current perspectives between metabolic syndrome and cancer 90
Transcriptionally active drugs improve adenovirus vector performance in vitro and in vivo 87
Semaphorin3A signaling controls Fas (CD95)-mediated apoptosis by promoting Fas translocation into lipid rafts 86
FLIP overexpression inhibits death receptor-induced apoptosis in malignant mesothelial cells 84
Integrin-mediated cell adhesion and spreading engage different sources of reactive oxygen species 83
The Neuroimmune Semaphorin-3A Reduces Inflammation and Progression of Experimental Autoimmune Arthritis. 82
5-Lipoxigenase regulates malignant mesothelioma cell survival: involvement of vascular endothelial growth factor. 77
Retinoids induce fibroblast growth factor-2 production in endothelial cells via retinoic acid receptor alpha activation and stimulate angiogenesis in vitro and in vivo 77
Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function 76
Metronomic administration of zoledronic acid and taxotere combination in castration resistant prostate cancer patients: Phase I ZANTE trial. 76
Experimental therapy of malignant mesothelioma: new perspectives from anti-angiogenic treatments 76
Iperespressione della 5-lipossigenasi nel carcinoma renale a cellule chiare. 73
Adenovirus-mediated wild-type p53 overexpression reverts tumourigenicity of human mesothelioma cells 73
Hyperglycemia promotes K-Ras-induced lung tumorigenesis through BASCs amplification 73
Angiogenesis and Mesothelioma 72
Expression of basic fibroblast growth factor, its receptors and syndecans in bladder cancer. 67
Characterization of human malignant mesothelioma cell lines orthotopically implanted in the pleural cavity of immunodeficient mice for their ability to grow and form metastasis 66
5-Lipoxygenase regulates senescence-like growth arrest by promoting ROS-dependent p53 activation 63
Semaphorins and their receptors in stem and cancer cells. 62
Increased expression of 5-lipoxygenase is common in clear cell renal carcinoma 62
The plexin-A1 receptor activates vascular endothelial growth factor-receptor 2 and nuclear factor-κ B to mediate survival and anchorage-independent growth of malignant mesothelioma cells 60
5-lipoxygenase antagonizes genotoxic stress-induced apoptosis by altering p53 nuclear trafficking 58
Induction of stem cell factor/c-Kit/slug signal transduction in multidrug-resistant malignant mesothelioma cells 58
Preclinical evaluation of the nonsteroidal anti-inflammatory agent celecoxib on malignant mesothelioma chemoprevention 55
Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen. 55
Enhanced antitumor therapy by inhibition of p21waf1 in human malignant mesothelioma 55
Cross-talk between vascular endothelial growth factor and semaphorin-3A pathway in the regulation of normal and malignant mesothelial cell proliferation 55
Basic fibroblast growth factor in mesothelioma pleural effusions: correlation with patient survival and angiogenesis 54
Expression of glycoprotein 90K in human malignant pleural mesothelioma: correlation with patient survival 53
Experimental therapy of malignant mesothelioma: new perspectives from anti-angiogenic treatments (Review). 52
Lipoxygenase inhibitors for cancer prevention: promises and risks 51
Oxidative Stress and Activation of Survival Pathways as a Basis for Mesothelioma Pathogenesis: New Perspectives for Experimental Therapy 50
Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma 50
The effects of insulin and insulin-like growth factors on tumor vascularization: new insights of insulin-like growth factor family in cancer 50
New aspects on the role of lipoxygenases in cancer progression 47
Phase II escalation study of sorafenib in patients with metastatic renal cell carcinoma who have been previously treated with anti-angiogenic treatment 41
Neuronal semaphorins regulate a primary immune response 40
The Plexin-A1 Receptor Activates Vascular Endothelial Growth Factor-Receptor 2 and Nuclear Factor-KB to Mediate Survival and Anchorage-Independent Growth of Malignant Mesothelioma Cells 39
semaphorins: a further chemotropic family expressed in the thymus 35
Methionine Aminopeptidase-2 regulates human mesothelioma cell survival: role on BCL-2 expression and telomerase activity 33
The Plexin-A1 Receptor Activates Vascular Endothelial Growth Factor-Receptor 2 and Nuclear Factor-{kappa}B to Mediate Survival and Anchorage-Independent Growth of Malignant Mesothelioma Cells. 30
Totale 3.058
Categoria #
all - tutte 14.981
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.981


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020174 0 0 0 0 0 3 51 0 48 3 1 68
2020/2021612 30 64 83 9 67 50 65 33 65 49 69 28
2021/2022373 23 124 0 23 5 21 15 17 23 28 30 64
2022/2023784 59 63 49 70 68 208 2 47 156 7 31 24
2023/2024364 71 10 29 58 59 67 3 4 3 8 7 45
2024/2025189 47 56 28 14 18 26 0 0 0 0 0 0
Totale 3.058